$28M Philly Xarelto Verdict Ripe For Reversal, Attys Say
After three prior bellwether trial losses, plaintiffs in litigation over the anticoagulant Xarelto are hoping to gain momentum following a $27.8 million verdict in Philadelphia on Tuesday, but attorneys say the...To view the full article, register now.
Already a subscriber? Click here to view full article